We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01559623
First Posted: March 21, 2012
Last Update Posted: December 16, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Zurich
March 19, 2012
March 21, 2012
December 16, 2014
January 2009
December 2011   (Final data collection date for primary outcome measure)
  • prevalence of ureaplasma urealyticum [ Time Frame: time of urogynecologic assessment ]
  • prevalence of mycoplasma hominis [ Time Frame: time of urogynecologic assessment ]
  • prevalence of neisseria gonorrhea [ Time Frame: time of urogynecologic assessment ]
  • prevalence of chlamydia trachomatis [ Time Frame: time of urogynecologic assessment ]
Not Provided
Complete list of historical versions of study NCT01559623 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms
Not Provided
The purpose of this study is to assess the prevalence of mycoplasma hominis, ureaplasma urealyticum, neisseria gonorrhea, and chlamydia trachomatis in women with overactive bladder symptoms, and to correlate these findings with cystoscopic and urodynamic findings.
Not Provided
Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
clinic for urogynecology
Overactive Bladder Syndrome
Procedure: retrospective data analysis
retrospective data analysis
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
766
February 2013
December 2011   (Final data collection date for primary outcome measure)

Inclusion criteria:

  • women with urogynecologic and urodynamic examination at our institution between 1.1.2009 and 31.12.2011

Exclusion criteria:

Sexes Eligible for Study: Female
16 Years and older   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
 
NCT01559623
OAB2012
Not Provided
Not Provided
Not Provided
University of Zurich
University of Zurich
Not Provided
Principal Investigator: David Amos Scheiner, MD University Hospital Zurich, Division of Gynecology
University of Zurich
December 2014